duplicate_img-

Grants and Funding

At RUSVM
GRANTS MANAGEMENT SPECIALIST

Robin Alexander
Box 334
Basseterre, St. Kitts, West Indies
[email protected]

Grants and Funding

The Grants Management Office (GMO) plays a pivotal role in research and program development and management by providing research administration services, systems, policies and processes to Ross University School of Veterinary Medicine project investigators and their support staff.

FUNDING OPPORTUNITIES

There are two basic types of funding, Intramural and Extramural.

Intramural projects are funded by Ross Vet. These are limited to a maximum budget of $25,000 and should be pilot studies or entry research.  Intramural funding is designed to “prime the pump” for your research….data from these projects can then be used to develop grant proposals for extramural funding.  

Intramural grant requests should be sent to your Research Center Director via email (cc’ the GMO at  [email protected]) for review and processing.  Intramural requests are due by February 15 of each year, and if funded will begin on July 1 of the same year; project duration is one year, July 1-June 30.  Intramural funds can be requested at any time during the fiscal year; approval and allocation are at the discretion of the Center Director.

Extramural funding is available from numerous sources including governments and private foundations. These grants are designed to further your research career.  Some sources are:

PREPARING YOUR GRANT PROPOSAL

Ready to start your grant proposal?  Your first step should be to contact the GMO at [email protected] to discuss your proposal and funding sources.

The GMO will work with you to compile the needed documents and information for your grant submission.  Each granting body has their own format, but the following are required for many proposals:

  • Biosketch
  • Facility Description
  • Letter of Support/Collaboration

The GMO office can provide templates and guidance in completing these and other documents needed for your submission.

Before submitting, all grant proposals must be reviewed by your Department Head and Center Director.  The GMO will review to ensure all required forms and documentation is complete.  Submission timelines vary depending on the granting agency, but you should plan for Department Head/Center Director review 3-4 weeks before the deadline.  A full copy of the proposal and budget with all documentation must be received by the GMO 2 weeks before the submission deadline.  After review and approval by the Dean, the GMO will then either submit on your behalf, or send you approval to submit your proposal directly to the granting agency.

We got the grant… now what do I do?

Congratulations!  Upon receiving a Notice of Award, the GMO will work with the granting agency to acquire your funding, set up an account for your funds, and help to track spending.  The GMO will work with you to ensure funds are spent in compliance with the granting agency’s regulations, and will assist in compiling and submitting progress and financial reports as required by the granting agency.

We are here for you! Contact the Grants Management Office at [email protected]
 

Institutional Review Board (IRB)

Any activity that meets either (a) the Department of Health and Human Services (DHHS) definition of both “research” and “human subjects” or (b) the Food and Drug Administration (FDA) definitions of both “clinical investigation” and “human subjects” requires review and approval by RUSVM IRB.
 

DHHS & FDA Definitions
Research (DHHS)

Research (DHHS): “A systematic investigation, including research development, testing, and evaluation, designed to develop or contribute to generalizable knowledge.  Activities that meet this definition constitute research for purposes of this policy, whether or not they are conducted or supported under a program that is considered research for other purposes.  For example, some demonstration and service programs may include research activities”. [45 CFR 46.102(l)]

Human Subject (DHHS)

Human Subject (DHHS):  “A living individual about whom an investigator (whether professional or student) conducting research: Obtains information or biospecimens through intervention or interaction with the individual, and uses, studies, or analyzes the information or biospecimens; or Obtains uses studies, analyzes, or generates identifiable private information or identifiable biospecimens.” [45 CFR 46.102(e)]

Human Subject (FDA)

Human Subject (FDA): “An individual who is or becomes a participant in research, either as a recipient of the test article or as a control. A subject may be either a healthy individual or a patient.” [21 CFR 56.102(e)] (Drug, Food, Biologic)

Clinical Investigation (FDA)

Clinical Investigation (FDA): “Involves use of a test article (i.e., drug, device, food substance or biologic), one or more human subjects, meets requirements for prior submission to FDA, or results are intended to be part of an application for research or marketing permit” [21 CFR 56.102]

RUSVM IRB New Submission Application 
RUSVM IRB Application Form 2020


For more information and assistance, please contact the IRB Administrator at: [email protected]